Randomized trial of two intravenous schedules of the topoisomerase I inhibitor liposomal lurtotecan in women with relapsed epithelial ovarian cancer: a trial of the national cancer institute of Canada clinical trials group. (Q36033853)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized trial of two intravenous schedules of the topoisomerase I inhibitor liposomal lurtotecan in women with relapsed epithelial ovarian cancer: a trial of the national cancer institute of Canada clinical trials group. |
scientific article |
Statements
Randomized trial of two intravenous schedules of the topoisomerase I inhibitor liposomal lurtotecan in women with relapsed epithelial ovarian cancer: a trial of the national cancer institute of Canada clinical trials group (English)
Graham G Dark
A Hilary Calvert
Robert Grimshaw
Christopher Poole
Ken Swenerton
Stan Kaye
Robert Coleman
Tien Le
Marc Trudeau
Paul Vasey
Marta Hamilton
Terri Cameron
Emma Barrett
Wendy Walsh
Lynn McIntosh
Elizabeth A Eisenhauer
7 February 2005